Pharmazac launched the new product Abelfiz / aripiprazole

Pharmazac launched the new product Abelfiz / aripiprazole 10, 15 and 30mg in hard tablets  for the treatment of schizophrenia in adults and in adolescents aged 15 years and older, for the treatment of moderate to severe manic episodes in bipolar I disorder and for the prevention of a new manic episode in adults who experienced predominantly manic episodes and whose manic episodes responded to aripiprazole treatment and  for the treatment up to 12 weeks of moderate to severe manic episodes in bipolar I disorder in adolescents aged 13 years and older.